COO vs TGTX: fair value comparison
The Cooper Companies, Inc. and TG Therapeutics, Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TGTX currently sits closer to the top of our discount ranking. COO carries the stronger quality grade.
| COO | TGTX | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $53.91 | $56.09 |
| 12-month range | $60.19–$83.92 | $29.18–$56.09 |
| Sector rank | #7 of 113 Healthcare | #4 of 113 Healthcare |
| Quality grade | B | C |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | Uptrend |
| 52-week position | The bottom quarter | The top quarter |
Full single-stock breakdowns: COO fair value analysis · TGTX fair value analysis